We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Systematic reviews and meta-analyses of randomised controlled trials have highlighted a dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors treated with omega-3-acid ethyl ester medicines compared to placebo.
Update of cardiovascular disease (CVD) data looking at heart disease, diabetes, kidney disease and stroke.
This article presents findings from a systematic review and meta-analysis
Update of cardiovascular disease (CVD) profile indicators for heart disease, diabetes, kidney disease and stroke data for commissioning organisations.
An exploratory study from Zhejiang, China
Caution is required if prescribing febuxostat in patients with pre-existing major cardiovascular disease, particularly, in those with evidence of high urate crystal and tophi burden or those initiating urate-lowering therapy.
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in clinical commissioning groups (CCG) areas.
Preventing people in England from developing high blood pressure (hypertension), and detecting and managing it better in those who have it.
The profiles provide an overview of data on cardiovascular and cardiovascular related conditions of heart disease, stroke, diabetes and kidney disease. Data will be available for England, integrated care boards and upper tier local authorities where available.
This study assesses if a cardiovascular disease care package was associated with improved lifestyle and biomedical indicators
These reports assess cardiovascular disease in the south-west, focusing on risk factors, heart disease, stroke, kidney disease and diabetes.
Digital NHS Health Check to be rolled out across England next spring delivering an additional one million checks in the first 4 years.
This document explains the NHS view on private screening for different conditions and diseases.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.